GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Gross-Profit-to-Asset %

Hugel (XKRX:145020) Gross-Profit-to-Asset % : 24.76% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Hugel Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hugel's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₩228,361 Mil. Hugel's average Total Assets over the quarter that ended in Mar. 2024 was ₩922,470 Mil. Therefore, Hugel's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 24.76%.


Hugel Gross-Profit-to-Asset % Historical Data

The historical data trend for Hugel's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hugel Gross-Profit-to-Asset % Chart

Hugel Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.88 16.08 18.01 21.25 24.88

Hugel Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.22 24.51 26.36 27.90 24.76

Competitive Comparison of Hugel's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Hugel's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hugel's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hugel's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hugel's Gross-Profit-to-Asset % falls into.



Hugel Gross-Profit-to-Asset % Calculation

Hugel's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=246162.831/( (1049782.929+929250.642)/ 2 )
=246162.831/989516.7855
=24.88 %

Hugel's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=228361.38/( (929250.642+915689.575)/ 2 )
=228361.38/922470.1085
=24.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Hugel Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hugel's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hugel (XKRX:145020) Business Description

Traded in Other Exchanges
N/A
Address
61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.

Hugel (XKRX:145020) Headlines

No Headlines